mRNA-LNP HIV-1 trimer boosters elicit precursors to broad neutralizing antibodies

Zhenfei Xie(Center for Excellence in Molecular Cell Science), Facundo D. Batista(Ragon Institute of MGH, MIT and Harvard), Andrea Carfı́(Moderna Therapeutics (United States)), Usha Nair(Ragon Institute of MGH, MIT and Harvard), Jon M. Steichen(Scripps Research Institute), Abigail M. Jackson(Scripps Research Institute), Jeong Hyun Lee(Scripps Research Institute), Michael Kubitz(Scripps Research Institute), John R. Yates(Scripps Research Institute), Jolene K. Diedrich(Scripps Research Institute), Sunny Himansu(Moderna Therapeutics (United States)), James C. Paulson(University of Michigan), Gabriel Ozorowski(Scripps Research Institute), Devin Sok(Scripps Research Institute), Ying‐Cing Lin(Lysosomal Therapeutics (United States)), Yumiko Adachi(Scripps Research Institute), Rashmi Ray(Ragon Institute of MGH, MIT and Harvard), Alessia Liguori(Scripps Research Institute), Stephanie R. Weldon(Ragon Institute of MGH, MIT and Harvard), Sara T. Richey(Scripps Research Institute), Gordon Dale(Ragon Institute of MGH, MIT and Harvard), Oleksandr Kalyuzhniy(Scripps Research Institute), William R. Schief(Scripps Research Institute), Andrew B. Ward(Scripps Research Institute), Jonathan L. Torres(Scripps Research Institute), Sven Kratochvil(BioNTech (Germany)), Erik Georgeson(Scripps Research Institute), Xuesong Wang(Ragon Institute of MGH, MIT and Harvard), Sabyasachi Baboo(Scripps Research Institute), Thavaleak Prum(Ragon Institute of MGH, MIT and Harvard), Reid M. Volk(Scripps Research Institute), John E. Warner(Ragon Institute of MGH, MIT and Harvard), Samantha Falcone(Moderna Therapeutics (United States)), Kathrin H. Kirsch(Ragon Institute of MGH, MIT and Harvard)
Science
May 16, 2024
Cited by 70


Related Papers